Your browser doesn't support javascript.
loading
Dual checkpoint inhibitor-associated eosinophilic enteritis.
Yang, J; Lagana, S M; Saenger, Y M; Carvajal, R D.
Affiliation
  • Yang J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lagana SM; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.
  • Saenger YM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Carvajal RD; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
J Immunother Cancer ; 7(1): 310, 2019 11 15.
Article in En | MEDLINE | ID: mdl-31730503
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Enteritis / Eosinophilia / Ipilimumab / Antineoplastic Agents, Immunological / Nivolumab / Gastritis Type of study: Risk_factors_studies Limits: Aged / Humans / Male Language: En Journal: J Immunother Cancer Year: 2019 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Enteritis / Eosinophilia / Ipilimumab / Antineoplastic Agents, Immunological / Nivolumab / Gastritis Type of study: Risk_factors_studies Limits: Aged / Humans / Male Language: En Journal: J Immunother Cancer Year: 2019 Document type: Article Affiliation country: United States Country of publication: United kingdom